Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
December 8, 2008
By: Tim Wright
Editor-in-Chief, Contract Pharma
BioMerieux has acquired PML Microbiologicals Inc., a provider of culture media and microbiological products in North America, for nearly $30 million. PML has manufacturing and marketing teams based in Portland, OR and Toronto, Canada. The acquisition will enable bioMerieux to become a leading provider in the U.S. of microbiology testing solutions for pharmaceutical companies, according to a company statement. In addition, bioMerieux will enter the North American clinical prepared culture media (PPM) market, becoming the top PPM provider for clinical applications in Canada. Founded in 1969, PML has 205 employees with 2007 sales of $24 million. BioMerieux purchased all of PML’s shares from the privately held Pelican Life Sciences Group for $29.6 million. PML has an range of products for use in the clinical and pharmaceutical industries, holding proprietary technologies for innovative culture media. PML specializes in reagents, including prepared culture media for sterility testing and environmental monitoring, as well as control organisms, which are complementary to bioMerieux’s offering. “This new acquisition, our sixth in two years, reinforces the North American market position of bioMerieux’s core business, microbiology,” declared Stephane Bancel, bioMerieux’s chief executive officer. “In the current challenging economic context, we are pleased to add another reagent-only business to our portfolio that will boost bioMerieux’s recurring sales.” “The PML acquisition brings to our customers in the pharmaceutical industry an enhanced range of high performance, innovative solutions for the control of their manufacturing environment and products,” added Alexandre Merieux, corporate vice president, Industrial Microbiology.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !